Literature DB >> 22488700

Cancer-related fatigue: implications for breast cancer survivors.

Ann M Berger1, Lynn H Gerber, Deborah K Mayer.   

Abstract

Cancer-related fatigue (CRF) has been documented as 1 of the most distressing symptoms reported by breast cancer survivors. CRF affects functioning and impacts quality of life. Possible causal factors include physical conditions, affective and cognitive states, proinflammatory cytokines, and metabolic factors. Several common problems are associated with CRF in women with breast cancer, including treatment side effects, obesity, arm/upper quadrant symptoms, sleep disturbances, psychological effects, and comorbid conditions. In this article, the authors review the state of the knowledge regarding these issues and nonpharmacologic and pharmacologic interventions for CRF. Physical activity and psychosocial interventions are recommended for practice. Numerous limitations of past studies need to be considered in the design of future studies. CRF is prevalent in preoperative, postoperative, and ongoing surveillance phases. Throughout the continuum of care for women with breast cancer, clinicians must screen, further assess as indicated, and treat CRF, because it is associated with emotional distress and limits function and willingness to exercise.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Year:  2012        PMID: 22488700     DOI: 10.1002/cncr.27475

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  91 in total

Review 1.  Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity.

Authors:  Kathryn H Schmitz; Marian L Neuhouser; Tanya Agurs-Collins; Krista A Zanetti; Lisa Cadmus-Bertram; Lorraine T Dean; Bettina F Drake
Journal:  J Natl Cancer Inst       Date:  2013-08-29       Impact factor: 13.506

Review 2.  The role of cytokines in breast cancer development and progression.

Authors:  Marcela Esquivel-Velázquez; Pedro Ostoa-Saloma; Margarita Isabel Palacios-Arreola; Karen E Nava-Castro; Julieta Ivonne Castro; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-07-28       Impact factor: 2.607

3.  Exploratory Investigation of Early Biomarkers for Chronic Fatigue in Prostate Cancer Patients Following Radiation Therapy.

Authors:  Li Rebekah Feng; Brian S Wolff; Nada Lukkahatai; Alexandra Espina; Leorey N Saligan
Journal:  Cancer Nurs       Date:  2017 May/Jun       Impact factor: 2.592

4.  A role for orexin in cytotoxic chemotherapy-induced fatigue.

Authors:  K B Weymann; L J Wood; X Zhu; D L Marks
Journal:  Brain Behav Immun       Date:  2013-11-09       Impact factor: 7.217

5.  Biobehavioral factors mediate exercise effects on fatigue in breast cancer survivors.

Authors:  Laura Q Rogers; Sandra Vicari; Rita Trammell; Patricia Hopkins-Price; Amanda Fogleman; Allison Spenner; Krishna Rao; Kerry S Courneya; Karen S Hoelzer; Randall Robbs; Steven Verhulst
Journal:  Med Sci Sports Exerc       Date:  2014-06       Impact factor: 5.411

6.  Recommendations for high-priority research on cancer-related fatigue in children and adults.

Authors:  Andrea M Barsevick; Michael R Irwin; Pamela Hinds; Andrew Miller; Ann Berger; Paul Jacobsen; Sonia Ancoli-Israel; Bryce B Reeve; Karen Mustian; Ann O'Mara; Jin-Shei Lai; Michael Fisch; David Cella
Journal:  J Natl Cancer Inst       Date:  2013-09-18       Impact factor: 13.506

7.  Gene Expression Profiling of Evening Fatigue in Women Undergoing Chemotherapy for Breast Cancer.

Authors:  Kord M Kober; Laura Dunn; Judy Mastick; Bruce Cooper; Dale Langford; Michelle Melisko; Alan Venook; Lee-May Chen; Fay Wright; Marilyn Hammer; Brian L Schmidt; Jon Levine; Christine Miaskowski; Bradley E Aouizerat
Journal:  Biol Res Nurs       Date:  2016-03-08       Impact factor: 2.522

8.  Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy.

Authors:  Kelley M Kidwell; Steven E Harte; Daniel F Hayes; Anna Maria Storniolo; Janet Carpenter; David A Flockhart; Vered Stearns; Daniel J Clauw; David A Williams; N Lynn Henry
Journal:  Cancer       Date:  2014-05-06       Impact factor: 6.860

9.  Patient and provider communication about employment following a cancer diagnosis.

Authors:  Janet S de Moor; Kisha Coa; Erin E Kent; Carmen Moten; Sarah Kobrin; Cheryl Altice; K Robin Yabroff
Journal:  J Cancer Surviv       Date:  2018-10-03       Impact factor: 4.442

10.  Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care.

Authors:  Janet S de Moor; Angela B Mariotto; Carla Parry; Catherine M Alfano; Lynne Padgett; Erin E Kent; Laura Forsythe; Steve Scoppa; Mark Hachey; Julia H Rowland
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-27       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.